Login / Signup

The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer.

Hung-Ming WangMin-Hsien WuPei-Hung ChangHung-Chi LinChun-Da LiaoSheng-Min WuTsung-Min HungChien-Yu LinTung-Chieh ChangTzu-Chen YenJason Chia-Hsun Hsieh
Published in: Head & neck (2019)
In chemoradiotherapy responders, CTCs are significantly reduced. CTC decline within the first month indicates a longer PFS and OS, suggesting that the dynamics of CTCs could be more important than CTC number alone.
Keyphrases
  • circulating tumor cells
  • locally advanced
  • rectal cancer
  • neoadjuvant chemotherapy
  • squamous cell carcinoma
  • radiation therapy
  • phase ii study
  • circulating tumor
  • free survival